Society-funded researchers will present exciting new directions in blood cancer research at the annual American Society of Hematology (ASH) conference this week at the Georgia World Congress Center in Atlanta. Especially noteworthy are new findings in immunotherapies, personalized medicine and targeting transcription factors....
Read More...
[Source: Society News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment